During Tuesday’s Current trade, Shares of Meritor Inc (NYSE:MTOR), gain 1.70% to $12.53.
Meritor, Inc. (NYSE: MTOR) continues to grow its aftermarket clutch offering by adding a self-adjusting 15.5″ model to its current Euclid® line for medium- and heavy-duty trucks.
Customers can purchase the new clutch, which comprises 15.5″ x 2″ models with seven springs or nine springs in four- and six-paddle options, from warehouse distributors stocking Euclid-branded parts. All units are new with no core charge. The clutch offers end users a 24-month/unlimited mileage warranty against defects in material and workmanship.
Unique features of the self-adjusting model comprise:
- New over-adjustment prevention technology
- Patent-pending Actively Expanding Seal (AES) provides anti-contamination enclosure
- Self-locking worm gear to ensure positive adjustment
- Installation employing the same procedure used for installing manually adjusted clutches
- Simple reset procedure (if required) that does not require clutch removal
Meritor, Inc. designs, develops, manufactures, sells, markets, distributes, services, and supports integrated systems, modules, and components to original equipment manufacturers (OEMs) and the aftermarket for the commercial vehicle, transportation, and industrial sectors.
Shares of Avnet, Inc. (NYSE:AVT), inclined 0.62% to $39.10, during its current trading session.
Avnet Electronics Marketing, an operating group of Avnet, Inc. (AVT), released the new Zynq®-7000 All Programmable SoC/Analog Devices Intelligent Drives Kit II. The kit is designed to provide a flexible platform for motor control and industrial networking development in sectors counting industrial automation, smart energy, medical and embedded systems. This evolution of the original Zynq-7000 All Programmable SoC/Analog Devices Intelligent Drives Kit offers improved performance features counting greater precision data converters from Analog Devices, higher frequency direct drive of the H-bridge power stages and simultaneous drive of two motors, counting bipolar steppers or BLDC with electronic brake.
Avnet, Inc., together with its auxiliaries, distributes electronic components, enterprise computer and storage products, IT solutions and services, and embedded subsystems in the Americas, Europe, the Middle East, Africa, and the Asia/Pacific. It operates through two segments, Electronics Marketing (EM) and Technology Solutions (TS).
Sunoco Logistics Partners L.P. (NYSE:SXL), during its Tuesday’s current trading session decreased -0.95% to $32.19.
ETP also owns the general partner, 100% of the incentive distribution rights, and about 67.1 million common units in Sunoco Logistics Partners L.P. (SXL), which operates a geographically diverse portfolio of crude oil and refined products pipelines, terminalling and crude oil acquisition and marketing assets. Energy Transfer Equity, L.P. stated that despite recent turmoil in the world energy and financial markets, it is confirming its merger proposal, under which ETE would acquire all of the outstanding common stock of The Williams Companies, Inc. (WMB) (“Williams” or “WMB”) at a fixed exchange ratio of 0.9358 ETE Corp shares for each Williams share, representing a 32.4% premium to the Williams common share closing price as of June 19, 2015, based on ETE’s unit price on the same date.
Despite comments made by Williams administration to research analysts and WMB stockholders, ETE continues to be open to engaging in the planned alternatives process declared by Williams, but only if it is fair and evenhanded and is not designed to disadvantage ETE (and ultimately WMB shareholders) or unduly restrict ETE’s ability to pursue the projected transaction.
Regardless of whether ETE take parts in the Williams process, ETE is ready to provide confidential information to WMB without material restrictions so that WMB and its Board can understand what ETE believes to be the truly unique and compelling investment and return characteristics accessible to the Williams stockholder from this combination.
Sunoco Logistics Partners L.P. transports, terminals, and stores crude oil, refined products, and natural gas liquids (NGLs). It operates through four segments: Crude Oil Pipelines, Crude Oil Acquisition and Marketing, Terminal Facilities, and Products Pipelines. The Crude Oil Pipelines segment transports crude oil primarily in Oklahoma and Texas. It contains about 5,300 miles of crude oil trunk pipelines, in addition to about 500 miles of crude oil gathering lines.
Finally, Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP), decreased -2.66%, to $1.88.
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, and serious inflammatory and fibrotic diseases, declared recently its financial results for the quarter ended June 30, 2015.
The Company also offered an update on its corporate progress and the clinical status for its investigational drug Resunab™, a novel oral drug that resolves chronic inflammation and fibrotic processes. Resunab is presently in a Phase 2 clinical study in skin-predominant dermatomyositis and is planned to commence Phase 2 clinical trials for the treatment of cystic fibrosis (“CF”) and diffuse cutaneous systemic sclerosis (“scleroderma”) during the third quarter.
Corporate Highlights
- Received a $5 million development award from Cystic Fibrosis Foundation for a Phase 2 clinical study in CF;
- Uplisted to The NASDAQ Capital Market and selected for inclusion in the FTSE Russell MicroCap® Index;
Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat rare life-threatening inflammatory and fibrotic diseases. Its lead product candidate, Resunab, is a novel oral anti-inflammatory drug that is predictable to commence Phase IIa clinical trials for the treatment of cystic fibrosis and diffuse systemic sclerosis diseases. The company is based in Norwood, Massachusetts.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
